Last reviewed · How we verify
NCT04170647
Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions
trial testing Plasminogen Activators in Stroke, Ischemic in 81 participants. Status unknown.
1 January 2020
Quick facts
| Lead sponsor | University of Medicine and Pharmacy at Ho Chi Minh City |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 81 |
| Start date | 1 October 2017 |
| Primary completion | 1 January 2020 |
| Estimated completion | 1 January 2020 |
| Sites | 1 location across Vietnam |
Drugs / interventions tested
- Plasminogen Activators — full drug profile →
Conditions studied
- Stroke, Ischemic — all drugs for Stroke, Ischemic →
- Stroke, Acute — all drugs for Stroke, Acute →
Sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Who can join
18 and older, any sex, with Stroke, Ischemic or Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational prospective study about the reperfusion rate of intravenous thrombolysis on ischemic stroke patients with large vessel occlusions and predictor factors of successful recanalization.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04170647
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke, Ischemic
Currently open trials in the same condition.
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
- NCT07135089 — Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban · Phase 3 · recruiting
- NCT07047014 — Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ische · Phase 3 · recruiting
Other University of Medicine and Pharmacy at Ho Chi Minh City trials
Trials by the same sponsor.
- NCT07530042 — Efficacy of Electroacupuncture Combined With Auricular Acupressure for Chronic Low Back Pain. · NA · not yet recruiting
- NCT07537439 — Evaluation of the Adjunctive Effects of Moxibustion in the Treatment of Cold-Syndrome Allergic Rhinitis · NA · not yet recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT07520071 — "Xuong Tan Lac Than" Exercise for Range of Motion and Muscle Endurance · NA · recruiting
- NCT07487181 — A Survey of Traditional Medicine Pattern Identification in Patients With Erectile Dysfunction · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04170647 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Medicine and Pharmacy at Ho Chi Minh City
- Last refreshed: 20 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04170647.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing